Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 1 | 2024 | 71 | 0.910 |
Why?
|
Circulating Tumor DNA | 1 | 2023 | 37 | 0.870 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 329 | 0.700 |
Why?
|
Neoplasms | 5 | 2023 | 2889 | 0.580 |
Why?
|
Plant Leaves | 2 | 2015 | 72 | 0.560 |
Why?
|
Brassica rapa | 1 | 2015 | 2 | 0.550 |
Why?
|
Quantitative Trait Loci | 3 | 2016 | 576 | 0.540 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 291 | 0.490 |
Why?
|
Zebrafish | 3 | 2023 | 307 | 0.490 |
Why?
|
Genome | 4 | 2023 | 371 | 0.480 |
Why?
|
Adaptation, Physiological | 2 | 2015 | 306 | 0.480 |
Why?
|
Phenotype | 6 | 2022 | 2375 | 0.460 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 1708 | 0.430 |
Why?
|
Receptors, Glucocorticoid | 3 | 2019 | 117 | 0.420 |
Why?
|
Genotype | 2 | 2017 | 1850 | 0.410 |
Why?
|
Databases, Genetic | 2 | 2021 | 259 | 0.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 1196 | 0.320 |
Why?
|
Genomics | 5 | 2021 | 710 | 0.320 |
Why?
|
Receptor, Serotonin, 5-HT2A | 2 | 2017 | 14 | 0.320 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 1381 | 0.300 |
Why?
|
Mutation | 5 | 2024 | 3952 | 0.300 |
Why?
|
Receptors, Estrogen | 2 | 2019 | 382 | 0.280 |
Why?
|
Genetic Variation | 3 | 2021 | 1349 | 0.270 |
Why?
|
Software | 3 | 2022 | 650 | 0.270 |
Why?
|
Neuroblastoma | 2 | 2021 | 374 | 0.270 |
Why?
|
Genomic Instability | 2 | 2022 | 79 | 0.250 |
Why?
|
Liquid Biopsy | 1 | 2023 | 33 | 0.230 |
Why?
|
Thymocytes | 1 | 2022 | 30 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 80 | 0.210 |
Why?
|
Cloud Computing | 1 | 2022 | 11 | 0.210 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2022 | 12 | 0.210 |
Why?
|
Data Accuracy | 1 | 2022 | 31 | 0.210 |
Why?
|
Antitubercular Agents | 1 | 2022 | 52 | 0.210 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 135 | 0.210 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2022 | 44 | 0.210 |
Why?
|
Whole Genome Sequencing | 1 | 2022 | 76 | 0.210 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 53 | 0.200 |
Why?
|
Translocation, Genetic | 1 | 2022 | 265 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 2350 | 0.200 |
Why?
|
Genome, Bacterial | 1 | 2022 | 139 | 0.200 |
Why?
|
Genome, Viral | 1 | 2021 | 74 | 0.190 |
Why?
|
DNA Methylation | 3 | 2021 | 622 | 0.190 |
Why?
|
beta Catenin | 1 | 2022 | 250 | 0.190 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 32 | 0.190 |
Why?
|
Humans | 24 | 2024 | 86281 | 0.190 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 415 | 0.190 |
Why?
|
Medical Oncology | 1 | 2024 | 357 | 0.180 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2021 | 272 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 427 | 0.180 |
Why?
|
Retrospective Studies | 2 | 2024 | 8431 | 0.180 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 145 | 0.180 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 184 | 0.180 |
Why?
|
Nicotinamide N-Methyltransferase | 1 | 2019 | 6 | 0.180 |
Why?
|
Precision Medicine | 1 | 2024 | 394 | 0.180 |
Why?
|
Haplotypes | 2 | 2023 | 642 | 0.170 |
Why?
|
Cancer-Associated Fibroblasts | 1 | 2019 | 36 | 0.170 |
Why?
|
Vitiligo | 1 | 2017 | 15 | 0.160 |
Why?
|
Endophenotypes | 1 | 2017 | 17 | 0.160 |
Why?
|
MicroRNAs | 2 | 2021 | 534 | 0.160 |
Why?
|
Biomedical Research | 1 | 2022 | 375 | 0.160 |
Why?
|
Proteomics | 1 | 2019 | 211 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 35 | 0.140 |
Why?
|
Chromatin | 1 | 2019 | 378 | 0.140 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 45 | 0.140 |
Why?
|
Brachypodium | 1 | 2016 | 7 | 0.140 |
Why?
|
Cysteine Endopeptidases | 1 | 2016 | 87 | 0.140 |
Why?
|
Personality | 1 | 2017 | 133 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2016 | 853 | 0.140 |
Why?
|
Penile Implantation | 1 | 2016 | 12 | 0.140 |
Why?
|
Penile Prosthesis | 1 | 2016 | 19 | 0.140 |
Why?
|
Immunotherapy | 1 | 2021 | 627 | 0.140 |
Why?
|
Penis | 1 | 2016 | 52 | 0.140 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 74 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2015 | 18 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 123 | 0.130 |
Why?
|
Prognosis | 5 | 2022 | 3669 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2016 | 203 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 175 | 0.130 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 144 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Ecotype | 1 | 2014 | 7 | 0.130 |
Why?
|
Panicum | 1 | 2014 | 5 | 0.130 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 554 | 0.130 |
Why?
|
Exome | 1 | 2015 | 127 | 0.130 |
Why?
|
Chlamydomonas reinhardtii | 1 | 2014 | 19 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 324 | 0.130 |
Why?
|
Water | 1 | 2016 | 274 | 0.120 |
Why?
|
Genetic Fitness | 1 | 2014 | 37 | 0.120 |
Why?
|
Reproductive Isolation | 1 | 2014 | 29 | 0.120 |
Why?
|
Phylogeny | 4 | 2022 | 1136 | 0.120 |
Why?
|
Breast Neoplasms | 2 | 2019 | 2881 | 0.120 |
Why?
|
Impulsive Behavior | 1 | 2017 | 281 | 0.120 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 738 | 0.120 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 388 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 546 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 329 | 0.110 |
Why?
|
Male | 8 | 2024 | 40860 | 0.110 |
Why?
|
Melanoma | 1 | 2016 | 454 | 0.110 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 2421 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2016 | 541 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2021 | 2699 | 0.100 |
Why?
|
Hypoxia | 1 | 2016 | 638 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 1917 | 0.100 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2021 | 70 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 2016 | 1195 | 0.090 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 67 | 0.090 |
Why?
|
Inflammation | 1 | 2015 | 913 | 0.090 |
Why?
|
Datasets as Topic | 2 | 2020 | 71 | 0.090 |
Why?
|
Female | 11 | 2021 | 44405 | 0.090 |
Why?
|
Quality of Life | 1 | 2017 | 1575 | 0.090 |
Why?
|
Biological Evolution | 1 | 2016 | 917 | 0.080 |
Why?
|
Genome, Human | 2 | 2021 | 756 | 0.070 |
Why?
|
Cohort Studies | 2 | 2022 | 2759 | 0.060 |
Why?
|
Animals | 5 | 2023 | 26518 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 739 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 455 | 0.060 |
Why?
|
United States | 3 | 2021 | 6637 | 0.060 |
Why?
|
Genetic Markers | 2 | 2016 | 476 | 0.060 |
Why?
|
Protein Binding | 2 | 2019 | 1454 | 0.060 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 1056 | 0.060 |
Why?
|
Disease Progression | 2 | 2019 | 1531 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2019 | 1135 | 0.060 |
Why?
|
Chromosomes | 1 | 2023 | 96 | 0.060 |
Why?
|
Computational Biology | 2 | 2016 | 528 | 0.050 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 63 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2019 | 2810 | 0.050 |
Why?
|
Transcriptome | 2 | 2016 | 574 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2016 | 1074 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2022 | 148 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 120 | 0.050 |
Why?
|
Adult | 5 | 2019 | 25577 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 1 | 2022 | 142 | 0.050 |
Why?
|
Chemokine CCL3 | 1 | 2021 | 12 | 0.050 |
Why?
|
Exons | 1 | 2023 | 450 | 0.050 |
Why?
|
RNA, Long Noncoding | 1 | 2022 | 102 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2021 | 111 | 0.050 |
Why?
|
Viruses | 1 | 2021 | 78 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 227 | 0.050 |
Why?
|
Information Dissemination | 1 | 2021 | 103 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 171 | 0.050 |
Why?
|
Controlled Before-After Studies | 1 | 2019 | 3 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2021 | 185 | 0.040 |
Why?
|
Health Information Exchange | 1 | 2019 | 12 | 0.040 |
Why?
|
S-Adenosylhomocysteine | 1 | 2019 | 9 | 0.040 |
Why?
|
S-Adenosylmethionine | 1 | 2019 | 15 | 0.040 |
Why?
|
Middle Aged | 4 | 2020 | 24957 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 5397 | 0.040 |
Why?
|
Niacinamide | 1 | 2019 | 116 | 0.040 |
Why?
|
HLA Antigens | 1 | 2020 | 232 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 230 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 567 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 2062 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 458 | 0.040 |
Why?
|
Survival Analysis | 1 | 2021 | 1536 | 0.040 |
Why?
|
Cell Cycle | 1 | 2019 | 502 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 266 | 0.040 |
Why?
|
Histones | 1 | 2019 | 309 | 0.040 |
Why?
|
Mice | 2 | 2022 | 11313 | 0.040 |
Why?
|
Macrophages | 1 | 2020 | 554 | 0.040 |
Why?
|
Base Sequence | 1 | 2021 | 2329 | 0.040 |
Why?
|
HLA-A Antigens | 1 | 2016 | 44 | 0.040 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 41 | 0.040 |
Why?
|
Cloning, Organism | 1 | 2016 | 19 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2021 | 694 | 0.040 |
Why?
|
Mental Health | 1 | 2017 | 160 | 0.040 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2016 | 14 | 0.040 |
Why?
|
Penile Induration | 1 | 2016 | 6 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 99 | 0.040 |
Why?
|
Response Elements | 1 | 2016 | 63 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2017 | 294 | 0.030 |
Why?
|
Cadaver | 1 | 2016 | 183 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 5961 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 269 | 0.030 |
Why?
|
Behavior, Addictive | 1 | 2017 | 130 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 133 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 360 | 0.030 |
Why?
|
Signal Transduction | 2 | 2016 | 3233 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2016 | 209 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 8968 | 0.030 |
Why?
|
Synteny | 1 | 2014 | 25 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 1040 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2014 | 171 | 0.030 |
Why?
|
Adipocytes | 1 | 2015 | 155 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 859 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 857 | 0.030 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 451 | 0.030 |
Why?
|
Dexamethasone | 1 | 2015 | 326 | 0.030 |
Why?
|
Hybridization, Genetic | 1 | 2014 | 104 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2014 | 124 | 0.030 |
Why?
|
Gene-Environment Interaction | 1 | 2014 | 103 | 0.030 |
Why?
|
Genetic Testing | 1 | 2017 | 535 | 0.030 |
Why?
|
Ultrasonography | 1 | 2016 | 695 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2019 | 1571 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 1801 | 0.030 |
Why?
|
Internet | 1 | 2015 | 309 | 0.030 |
Why?
|
Aged | 2 | 2020 | 18353 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2019 | 2227 | 0.030 |
Why?
|
Gene Expression | 1 | 2016 | 1281 | 0.030 |
Why?
|
Genetics, Population | 1 | 2014 | 394 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2016 | 1932 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 1611 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2016 | 1456 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2017 | 2495 | 0.020 |
Why?
|
Algorithms | 1 | 2015 | 1828 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 6481 | 0.020 |
Why?
|